Zoom in for HER2+ space: Pharmacology & clinical (efficacy and safety) for trastuzumab deruxtecan Later lines of treatment
Host: Doz. Dr. Christiane Thallinger
Univ. Prof. Dr. Evandro De Azambuja
Institut Jules Bordet
Belgium
Univ. Prof. Dr. Christoph Zielinski
Professor of Medical Oncology and Clinical Immunology
Medical Director, Wiener Privatklinik and Central European Cancer Center
Wien, Austria
President, Central European Cooperative Oncology Group (CECOG)
Editor in Chief, "ESMO Open - Cancer Horizons", 2016-2021
Zoom in for HER2+ space: Pharmacology & clinical (efficacy and safety) for trastuzumab deruxtecan Later lines of treatment
Host: Doz. Dr. Christiane Thallinger
Univ. Prof. Dr. Evandro De Azambuja
Institut Jules Bordet
Belgium
Univ. Prof. Dr. Christoph Zielinski
Professor of Medical Oncology and Clinical Immunology
Medical Director, Wiener Privatklinik and Central European Cancer Center
Wien, Austria
President, Central European Cooperative Oncology Group (CECOG)
Editor in Chief, "ESMO Open - Cancer Horizons", 2016-2021